Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

about

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease

Item

http://www.wikidata.org/entity/Q58549444

description

scientific article published on 27 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Relationship between Serum Cyt ...... nalcoholic Fatty Liver Disease

@en

Relationship between Serum Cyt ...... nalcoholic Fatty Liver Disease

@nl

type

Item

label

Relationship between Serum Cyt ...... nalcoholic Fatty Liver Disease

@en

Relationship between Serum Cyt ...... nalcoholic Fatty Liver Disease

@nl

prefLabel

Relationship between Serum Cyt ...... nalcoholic Fatty Liver Disease

@en

Relationship between Serum Cyt ...... nalcoholic Fatty Liver Disease

@nl

P1476

Relationship between Serum Cyt ...... nalcoholic Fatty Liver Disease

@en

P2093

Nazefah Abd Hamid

http://www.w3.org/2001/XMLSchema#string

Ngiu Chai Soon

http://www.w3.org/2001/XMLSchema#string

Rafiz Abdul Rani

http://www.w3.org/2001/XMLSchema#string

Shamsul Azhar Shah

http://www.w3.org/2001/XMLSchema#string

Wong Zhi Qin

http://www.w3.org/2001/XMLSchema#string

Yazmin Yaakob

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

Fibroscan (transient elastography) for the measurement of liver fibrosis

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease.

Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: A meta-analysis.

P304

9252536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/9252536

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

S Kosasih

Raja Affendi Raja Ali

P577

2018-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30363686

http://www.w3.org/2001/XMLSchema#string

P932

6180970

http://www.w3.org/2001/XMLSchema#string